Error: Could not add to watchlist. X
+ Watchlist

Matinas BioPharma Holdings Inc

6LJ:GR
Frankfurt
2.14
EUR
0.14
5.98%
As of 9:35 AM EDT 6/23/2017
Open
2.21
Day Range
2.14 - 2.21
Volume
0
Previous Close
2.28
52Wk Range
1.97 - 2.98
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.21
Day Range
2.14 - 2.21
Volume
0
Previous Close
2.28
52Wk Range
1.97 - 2.98
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
195.590
Shares Outstanding (m)
91.397
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.23%
% Price Change
-0.30%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Matinas BioPharma Holdings, Inc. operates as a clinical-stage biopharmaceutical company focused on identifying and developing effective anti-fungal and anti-bacterial therapeutics for the treatment of serious or life threatening infections.
Address
1545 Route 206
Suite 302
Bedminster, NJ 07921
United States
Phone
908-443-1860
  • Roelof Rongen
    CEO/Co-Founder
  • Jerome D Jabbour
    President
  • Abdel A Fawzy
    Exec VP:Pharmaceutical
  • Raphael J Mannino
    Senior VP/Chief Scientific Ofcr
  • Douglas F Kling
    Senior VP:Clinical Dev
Show More